Clinical Trials on Progressive Desmoids Tumors in China

Total 2478 results

Novartis Pharmaceuticals

Completed

An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor

Advanced Solid Tumors

Japan
Peking University Cancer Hospital & Institute

Recruiting

Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma

Melanoma | Temozolomide | Apatinib | Camrelizumab | Acral Melanoma | Neoadjuvant | Pathological Response

China
Hervor Therapeutics
Renmin Hospital of Wuhan University

Recruiting

HV-101 for Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Peking University People's Hospital

Unknown

PD-L1 Expression in Advanced Osteosarcoma

Progression | Survival

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Trial of SHR-1802 in Patients With Failure of Standard Treatment for Advanced Malignant Tumours

Malignant Tumours

China
Hutchison Medipharma Limited

Completed

Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors

Neuroendocrine Tumors

China
First Affiliated Hospital of Zhejiang University
Zhejiang Cancer Hospital; West China Hospital; Third Affiliated Hospital, Sun... and other collaborators

Recruiting

A Multicenter, Randomized, Parallel-controlled Clinical Trial Protocol to Validate the Safety and Efficacy of a Steep Pulse Therapy System for the Treatment of Liver Tumors

A Steep Pulse Therapy System for the Treatment of Liver Tumors

China
LaNova Medicines Limited

Suspended

A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors

Malignant Tumors

China
Shanghai Institute Of Biological Products
Fudan University

Completed

A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors.

Tumor

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Tolerance and Pharmacokinetics of TQ-B3233

Tumor

China
Shenzhen Geno-Immune Medical Institute
Shenzhen Children's Hospital

Recruiting

4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma

Neuroblastoma

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Safety and Tolerability of SHR-1316 in Subjects With Advanced Tumors

Tumor

China
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Zhejiang Cancer Hospital; Fudan University

Recruiting

IMM2510, a PD-L1 and VEGF Bispecific Fusion Protein, in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
SYZ Cell Therapy Co..

Recruiting

A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Peking Union Medical College Hospital

Completed

The Efficacy and Safety of Temozolomide in Patients With MPPGL (MPPGL)

Pheochromocytoma, Metastatic | Paraganglioma, Malignant | Pheochromocytoma Malignant

China
Bio-Thera Solutions

Recruiting

A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors

Advanced Solid Tumors

China
Grit Biotechnology

Recruiting

TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors

Solid Tumors, Adult

China
Peking Union Medical College Hospital

Completed

Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms

Pancreatic Neuroendocrine Tumors

China
Tianjin Medical University Cancer Institute and...

Recruiting

Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine Carcinoma

Gastric Neuroendocrine Carcinoma

China
Hutchison Medipharma Limited

Recruiting

A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine Carcinoma

Advanced Neuroendocrine Carcinoma

China
Peking University Cancer Hospital & Institute

Unknown

Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma

Melanoma

China
RemeGen Co., Ltd.

Recruiting

A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours

Advanced Solid Tumours

China
AstraZeneca

Completed

Capivasertib China PK Study

Advanced Solid Tumours

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Acral Malignant Melanoma

Advanced Acral Malignant Melanoma

China
Sun Yat-sen University

Unknown

Molecular Profiling and Molecular Labeling of Inflammatory Myofibroblastic Tumor

Inflammatory Myofibroblatic Tumor

China
Peking University Cancer Hospital & Institute

Unknown

Phase II Study in the Treatment of Patients With Advanced Mucinous Melanoma (BJCH-MM-0624)

Advanced Mucosal Melanoma

China
Peking Union Medical College Hospital

Recruiting

First- Line Treatment With Durvalumab Plus XELOX Chemotherapy in Advanced Gastrointestinal Neuroendocrine Carcinoma

Gastrointestinal Neuroendocrine Carcinoma

China
Eli Lilly and Company

Recruiting

A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors

Advanced Solid Tumors

China
Shanghai Antengene Corporation Limited

Terminated

A Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG 016 Monotherapy in Patients With Advanced Solid Tumors (REACH)

Advanced Solid Tumors

China
Peking University People's Hospital
Shanghai Hansen Biopharmaceutical Technology Co., Ltd; MEDx Translational Medicine...

Recruiting

Soluble B7-H3 as a Biomarker for Osteosarcoma

Progression | Osteosarcoma | Surveillance | Biomarker

China
Shanghai Cell Therapy Group Co.,Ltd

Recruiting

An Exploratory Study by Fast CAR T Cells

Solid Tumor

China
Biotheus Inc.

Recruiting

A Study of PM1009 (Anti-TIGIT/PVRIG) in Patients With Advanced Tumours

Advanced Tumor

China
Peking University Cancer Hospital & Institute

Completed

Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

Solid Tumor

China
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

Study of ICP-105 in Solid Tumors Patients

Solid Tumor

China
AnHeart Therapeutics Inc.

Completed

A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin

Solid Tumor

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Fudan University

Unknown

A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics

Solid Tumor

China
Nanjing Sike Pharmaceutical Co., Ltd.

Unknown

Clinical Study of Liposomal Paclitaxel in Chinese Patients

Solid Tumor

China
Nanfang Hospital of Southern Medical University

Unknown

ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors

Leiomyoma | Upper Gastrointestinal Submucosal Tumors (SMTs) | Gastrointestinal Stromal Tumors (GISTs)

China
Peking University
Qilu Pharmaceutical Co., Ltd.

Recruiting

Nab-paclitaxel Combined With Bevacizumab in the Treatment of Metastatic Neuroendocrine Carcinoma

Neuroendocrine Carcinoma

China
Innovent Biologics (Suzhou) Co. Ltd.

Terminated

The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery

Acral Melanoma That Has Been Removed by Surgery

China
Wuhan Union Hospital, China

Not yet recruiting

A Single-arm, Open-label, Clinical Trial of Surufatinib/Serplulimab/Platinum/Etoposide in Neuroendocrine Carcinoma.

Neuroendocrine Carcinoma

China
Xiangya Hospital of Central South University

Unknown

A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma

Melanoma (Skin)

China
Chinese PLA General Hospital

Recruiting

Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors

Malignant Solid Tumours

China
Henan Cancer Hospital

Unknown

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Advanced Cancer | Mucosal Melanoma | Apatinib | SHR-1210

China
Eisai Co., Ltd.

Completed

A Study of E7050 Administered Orally to Patients With Advanced Solid Tumors

Solid Tumors

Japan
Novartis Pharmaceuticals

Completed

A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor.

Advanced Solid Tumors

Japan
Varian, a Siemens Healthineers Company

Completed

Varian ProBeam Proton Therapy System Clinical Trial (Shandong)

Tumor, Solid

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Bioequivalence Study of Famitinib Malate in Healthy Volunteers Under Fasting Condition

Solid Tumor

China
AnHeart Therapeutics Inc.

Completed

A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK

Solid Tumor

China
Peking University Third Hospital

Completed

Analysis the Positive Rate of Tumor Markers Among Physical Examination Population

Tumor

China

Clinical Trials on Progressive Desmoids Tumors in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations